🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
The purpose of the study is to determine whether, in patients with moderate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00941031
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The purpose of this study was to demonstrate efficacy of autoinjector admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-17
Trial ID
NCT01636687
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2022-10-26
Trial ID
NCT05377944
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Arizona Arthritis and Rheumatology Associates PLLC
Start Date
2023-03-22
Trial ID
NCT05767034
Treatments Being Tested
The purpose of the present study was to assess the efficacy of secukinumab ...
Status
Terminated
Location
Millennium Clinical Trials
Start Date
2023-08-10
Trial ID
NCT05722522
Treatments Being Tested